[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544793":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":10,"responsibleParty":25,"collaborators":10,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":32,"acronym":33,"eligibilityCriteria":34,"healthyVolunteers":35,"sex":36,"minAge":37,"maxAge":38,"enrollmentInfo":39,"targetDuration":10,"studyType":42,"phases":43,"briefSummary":45,"conditions":46,"keywords":10,"overallStatus":48,"whyStopped":10,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":10},{"fullName":5,"class":6},"CerbaXpert","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Observational arm",null,[12],"Biological: Blood collection",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"BIOLOGICAL","Blood collection","Collection of blood before and after a non mandatory vaccination",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Barbara Perniconi","CONTACT","0671296728","bperniconi@cerbaresearch.com",{"type":26,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100544793","longitudinal-evaluation-of-antibody-kinetics-of-vaccinated-patients-with-non-mandatory-vaccine-following-administration-of-a-non-public-marketed-vaccine-in-the-general-population-real-life-study-100544793",false,"NCT06373510","Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration of a Non-public Marketed Vaccine in the General Population, Real-life Study","Longitudinal Evaluation of Antibody Kinetics Following Administration of a Non-mandatory Marketed Vaccine in the General Population, Real-life Study","ELCAV","Inclusion Criteria:\n\n* Subject over 18 years of age\n* Subject presenting to the investigation centre as part of its usual management (prevention, screening, tracking)\n* Subject who has been vaccinated and\u002For wishes to be vaccinated\n* Subject able to understand the purpose of research that has given free and informed express consent\n* Member or beneficiary of a social security scheme\n\nExclusion Criteria:\n\n* Protected subject: major under guardianship, curatorship or other legal protection, deprived of liberty by decision judicial or administrative",true,"ALL","18 Years","90 Years",{"count":40,"type":41},10000,"ESTIMATED","INTERVENTIONAL",[44],"NA","The study would make it possible to document more explicitly the evolution of antibody titers at following a non-public vaccination over a large post-vaccination period in the French population .\n\nAnalysis of real-life data would enhance knowledge of vaccine response kinetics It would be useful to identify possible early declines requiring doses Similarly, by analyzing antibody kinetics by age, sex, and vaccination status, the would be possible to determine whether there are differences in the immune response between these different sub-groups. In addition, it would provide additional information to assess the real impact of these non-public vaccines in public health and guide vaccine policies.",[47],"Vaccination Reaction","NOT_YET_RECRUITING","2024-04-15",{"date":51,"type":52},"2024-04-18","ACTUAL",{"date":54,"type":41},"2024-06-20",{"date":56,"type":41},"2027-04-03",{"name":5,"class":6}]